# Cardiovascular Effects of CART Cell Therapy

> **NCT04026737** · — · COMPLETED · sponsor: **Abramson Cancer Center at Penn Medicine** · enrollment: 44 (actual)

## Conditions studied

- Leukemia
- Lymphoma
- Cardiotoxicity
- Risk Factor, Cardiovascular
- Immunotherapy

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04026737
- **Lead sponsor:** Abramson Cancer Center at Penn Medicine
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-07-22
- **Primary completion:** 2022-11-16
- **Final completion:** 2022-11-16
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2026-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04026737

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04026737, "Cardiovascular Effects of CART Cell Therapy". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04026737. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*